Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The Scientific Document Committee (SDC) was established by the board of the European Heart Rhythm Association in 2006 with the aim of supervising and monitoring the preparation of Scientific Documents Statements and documents such as expert consensus and position papers. The committee was created to meet the need for thorough and comprehensive guidance on a number of issues in clinical arrhythmia management which cannot all be met by ESC guidelines.
The purpose of a scientific statement of EHRA is to give a comprehensive and balanced overview of the chosen topic, to summarize existing knowledge, to identify evidence gaps, and to point to areas in need of improvement in the implementation. By these documents, EHRA voices the needs of European cardiologists with a special interest in arrhythmias and responds to emerging clinical issues.
At least one representative of the Endorsing Society has to be part of the document (writing group and/or review process) even without being officially nominated. If no representative of the Endorsing Society is part of the document, the Requesting Society may still offer the opportunity to review and endorse the Requesting Society’s document.
The Endorsing Society can choose to decline endorsement.
The Requesting Society must ensure to leave at least 4 weeks to the Endorsing Society to review the document.
The Endorsing Society reserves the right to amend, extend or alter in any way the terms of the endorsement. i.e for HRS when some parts of the document are not applicable in the countries represented by the Endorsing Society.
Within EHRA the document will be reviewed internaly by the EHRA Scientific Documents Committee (2 weeks maximum) and the EHRA Executive Board (2 weeks maximum).
© 2017 European Society of Cardiology. All rights reserved